REVIEW OF REIMBURSEMENT DECISION DRIVERS FOR RARE CANCER THERAPIES ACROSS EU5 MARKETS

被引：0
|
作者：
Gupta, J. [1 ]
Wahal, V. P. [2 ]
机构：
[1] DRG Abacus, Gurgaon, India
[2] DRG Market Access Insights, Gurgaon, India
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.965
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY138
引用
收藏
页码：A569 / A569
页数：1
相关论文
共 50 条
  • [21] Impact of reimbursement process on annual per patient cost in severe haemophilia in the EU5
    O'Hara, Jamie
    Burke, Tom
    Camp, Charlotte
    HAEMOPHILIA, 2018, 24 : 152 - 152
  • [22] DELAY BETWEEN HIV DIAGNOSIS AND TREATMENT INITIATION ACROSS THE EU5
    Deemer, J.
    Bradshaw, K.
    Yaacob, N. B.
    VALUE IN HEALTH, 2018, 21 : S234 - S234
  • [23] Immigrants in the EU5 labour markets: what happened during the economic crisis?
    Quintano, Claudio
    Mazzocchi, Paolo
    Rocca, Antonella
    INTERNATIONAL JOURNAL OF MANPOWER, 2020, 41 (01) : 68 - 83
  • [24] WORTH THEIR WEIGHT? AN OVERVIEW OF THE INITIAL REIMBURSEMENT DECISIONS FOR GLP-1s IN THE EU5
    Tzaras, D.
    Macaulay, R.
    VALUE IN HEALTH, 2024, 27 (12) : S365 - S365
  • [25] IDENTIFYING THE KEY CHALLENGES AFFECTING THE REIMBURSEMENT OF CAR-T THERAPIES IN THE EU5 USING A WEB-BASED PORTAL TO ENGAGE PAYERS
    Singh, Kumar K.
    Clapton, G. S.
    Gray, P. M.
    Bhalla, S.
    VALUE IN HEALTH, 2018, 21 : S62 - S62
  • [26] PATIENT CHARACTERISTICS AND REASONS FOR BIOLOGIC MONOTHERAPY IN EU5 MARKETS IN RHEUMATOID ARTHRITIS
    Sullivan, E.
    Kershaw, J.
    Blackburn, S.
    Mahajan, P.
    Boklage, S.
    VALUE IN HEALTH, 2017, 20 (09) : A539 - A539
  • [27] Therapy switching trends and drivers among moderate and severe haemophilia A patients in EU5
    Palau, Isabel
    Brown, S.
    Rosli, A.
    Seth, E.
    Amirah, A.
    HAEMOPHILIA, 2020, 26 : 65 - 65
  • [28] USE OF EPISODIC THERAPY IN MODERATE/SEVERE HEMOPHILIA A PATIENTS ACROSS THE EU5
    Kyle, A.
    Brown, S.
    Yaacob, N. B.
    Rosli, A.
    Eryse, S.
    VALUE IN HEALTH, 2019, 22 : S924 - S924
  • [29] Treatment pattern differences across the United States and EU5 among patients with ovarian cancer.
    Karki, Chitra
    Patel, Ripsi
    Martino, Samantha
    Wriede, Valerie
    Shah-Manek, Bijal
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] ANTICIPATED IMPACT OF EU5 PAYER POLICY ON PRESCRIBING OF NOVEL BIOLOGIC THERAPIES IN ASTHMA
    DiModica, L.
    Kozhemyakina, E.
    VALUE IN HEALTH, 2016, 19 (07) : A559 - A560
12345